News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Evoke Pharma, Inc. Files $24 Million IPO



5/31/2013 7:40:36 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Evoke Pharma (NASDAQ: EVOK) filed a $24 million IPO on form S-1 with the SEC this afternoon. The company plans to list its shares on the NASDAQ under the trading symbol "EVOK." Aegis Capital is the lone underwriter at this point. Evoke Pharma is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal, or GI, disorders and diseases. The company is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus.

Help employers find you! Check out all the jobs and post your resume.

Read at Street Insider
Read at Nasdaq
Read at Seeking Alpha


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES